Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. MASS
stocks logo

MASS

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
12.17M
-13.38%
-0.145
-53.45%
14.15M
-15.62%
-0.100
-67.27%
16.25M
-13.67%
-0.045
-83.95%
Estimates Revision
The market is revising No Change the revenue expectations for 908 Devices Inc. (MASS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 22.24%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+22.24%
In Past 3 Month
Wall Street analysts forecast MASS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASS is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast MASS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASS is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 6.650
sliders
Low
6.00
Averages
6.00
High
6.00
Current: 6.650
sliders
Low
6.00
Averages
6.00
High
6.00
Leerink
Puneet Souda
Market Perform -> Outperform
upgrade
$12
2025-08-05
Reason
Leerink
Puneet Souda
Price Target
$12
2025-08-05
upgrade
Market Perform -> Outperform
Reason
Leerink analyst Puneet Souda upgraded 908 Devices to Outperform from Market Perform with a $12 price target.
Leerink
analyst
Market Perform
to
Outperform
upgrade
$7 -> $12
2025-08-05
Reason
Leerink
analyst
Price Target
$7 -> $12
2025-08-05
upgrade
Market Perform
to
Outperform
Reason
As previously reported, Leerink upgraded 908 Devices to Outperform from Market Perform with a price target of $12, up from $7. After the recent life science divestiture, 908 has "turned into a forensics and threat detection pure-play," says the analyst, who notes that the One Big Beautiful Act releases funds for enforcement, security, drug and broader threat detection. 908 is guiding to 15% pro-forma growth for the year, but expecting an acceleration in 2026, notes the analyst, who sees upside to the company's 20%-plus growth expectation for 2026.
Stephens & Co.
Jacob Johnson
Buy
Reiterates
$6
2025-01-15
Reason
Stephens & Co.
Jacob Johnson
Price Target
$6
2025-01-15
Reiterates
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for 908 Devices Inc (MASS.O) is -19.94, compared to its 5-year average forward P/E of -21.44. For a more detailed relative valuation and DCF analysis to assess 908 Devices Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-21.44
Current PE
-19.94
Overvalued PE
4.11
Undervalued PE
-46.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-21.86
Current EV/EBITDA
-17.95
Overvalued EV/EBITDA
9.58
Undervalued EV/EBITDA
-53.31

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
10.05
Current PS
4.41
Overvalued PS
20.21
Undervalued PS
-0.10
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 155.47% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

MASS News & Events

Events Timeline

(ET)
2025-11-10
07:21:39
908 Devices reaffirms FY25 revenue forecast of $54M-$56M, aligning with consensus of $55.42M
select
2025-11-10
07:20:49
908 Devices announces Q3 earnings per share of 41 cents, surpassing consensus estimate of 12 cents.
select
2025-10-28 (ET)
2025-10-28
07:55:51
908 Devices reveals Coast Guard acquisition of 23 MX908 units
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
5.0
11-05TipRanks
Cathie Wood Increases Investment in Veracyte Before Earnings Surprise, Reduces Biotech Portfolio

  • Portfolio Adjustments: Cathie Wood's Ark Invest has reduced its holdings in several biotech companies, including 10X Genomics and Crispr Therapeutics, indicating a shift away from volatile biotech stocks towards more stable growth sectors.

  • Investment in Veracyte: Ark made a significant investment in Veracyte, purchasing over 665,690 shares, which saw a strong earnings report that exceeded expectations, leading to a 16% stock surge.

  • Roku Stake Reduction: The firm also sold more than 1.1 million shares of Roku as part of a strategy to trim its portfolio, influenced by ongoing legal issues facing the company.

  • Analyst Consensus on Veracyte: Analysts maintain a Moderate Buy consensus on Veracyte, with an average 12-month price target suggesting a potential downside from the current price, reflecting cautious optimism about the stock's future performance.

[object Object]
Preview
6.0
10-16Newsfilter
U.S. Marine Corps Acquires 908 Devices' XplorIR Gas Detection Technology

  • Purchase of XplorIR Devices: The U.S. Marine Corps CBRNE Installation and Protection Program has acquired 17 XplorIR devices from 908 Devices Inc. for the identification and quantification of hazardous gases and vapors, enhancing safety measures against CBRNE threats.

  • Capabilities of XplorIR: The handheld XplorIR device can detect and identify over 5,000 chemical threats in real-time, allowing first responders to make informed decisions while operating in hazardous environments.

[object Object]
Preview
2.0
09-22NASDAQ.COM
908 Devices (MASS) Rises 7.0%: Could This Signal More Growth Ahead?

  • Stock Performance: 908 Devices Inc. (MASS) shares rose 7% to $7.3, reflecting strong investor optimism and a 13.3% gain over the past month, despite an expected quarterly loss of $0.11 per share.

  • Financial Restructuring: The company has improved its financial position by reducing facility space by 44% and workforce by 39% year-over-year, while maintaining a Zacks Rank of #3 (Hold).

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is 908 Devices Inc (MASS) stock price today?

The current price of MASS is 6.65 USD — it has increased 6.91 % in the last trading day.

arrow icon

What is 908 Devices Inc (MASS)'s business?

908 Devices Inc. is revolutionizing chemical analysis with its simple handheld and desktop devices, addressing life-altering applications. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.

arrow icon

What is the price predicton of MASS Stock?

Wall Street analysts forecast MASS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MASS is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is 908 Devices Inc (MASS)'s revenue for the last quarter?

908 Devices Inc revenue for the last quarter amounts to 11.78M USD, increased 58.68 % YoY.

arrow icon

What is 908 Devices Inc (MASS)'s earnings per share (EPS) for the last quarter?

908 Devices Inc. EPS for the last quarter amounts to 1.23 USD, decreased -472.73 % YoY.

arrow icon

What changes have occurred in the market's expectations for 908 Devices Inc (MASS)'s fundamentals?

The market is revising No Change the revenue expectations for 908 Devices Inc. (MASS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 22.24%.
arrow icon

How many employees does 908 Devices Inc (MASS). have?

908 Devices Inc (MASS) has 246 emplpoyees as of December 05 2025.

arrow icon

What is 908 Devices Inc (MASS) market cap?

Today MASS has the market capitalization of 177.60M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free